enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Army Substance Abuse Program - Wikipedia

    en.wikipedia.org/wiki/Army_Substance_Abuse_Program

    The Army Substance Abuse Program is an anti-substance abuse program in the United States Army, operated by the Army Center for Substance Abuse Programs.. The program is governed by AR 600-85, MEDCOM Reg 40-51, ALARACT 062/2011, DA Pam 600-85, and the Employee Assistance Program (EAP).

  3. McCarran Internal Security Act - Wikipedia

    en.wikipedia.org/wiki/McCarran_Internal_Security_Act

    The ALARACT refers to AR 190-11 and public law (section 1062 of Public Law 111–383, also known as the National Defense Authorization Act for Fiscal Year 2011); AR 190–11 in turn cites the McCarran Internal Security Act (codified as 50 USC 797). The ALARACT reference is a truncated version of the public law. [27]

  4. Basic Leader Course - Wikipedia

    en.wikipedia.org/wiki/Basic_Leader_Course

    U.S. Army student squad leaders are evaluated by a Noncommissioned Officer (NCO) Academy instructor during a mission preparation exercise at Camp Buehring, Kuwait. The Basic Leader Course (BLC), [1] [2] formerly the Warrior Leader Course (WLC) and Primary Leadership Development Course (PLDC), is the first course of study in the US Army noncommissioned officer Professional Development System ...

  5. AN/PRC-163 - Wikipedia

    en.wikipedia.org/wiki/AN/PRC-163

    The AN/PRC-163 Multi-channel Handheld Radio, is a dual-channel tactical handheld radio manufactured by L3Harris Technologies, Inc. for the U.S. military, referred to by the U.S. Army as the Leader Radio. [1]

  6. Consolidated Appropriations Act, 2023 - Wikipedia

    en.wikipedia.org/wiki/Consolidated...

    President Joe Biden signs the Consolidated Appropriations Act of 2023 in St. Croix on December 29, 2022. The Consolidated Appropriations Act, 2023 is a $1.7 trillion omnibus spending bill funding the U.S. federal government for the 2023 fiscal year.

  7. JHU-083 - Wikipedia

    en.wikipedia.org/wiki/JHU-083

    JHU-083 is an experimental drug which acts as a glutaminase inhibitor.It is a prodrug which is cleaved in vivo to the active form 6-diazo-5-oxo-L-norleucine.It has been researched for the treatment of various neurological conditions such as depression, Alzheimer's disease, and cerebral malaria, [1] [2] [3] as well as multiple sclerosis, [4] atherosclerosis, [5] hepatitis, [6] and some forms of ...